• #904182
  • 19
  • Genentech USA #50242008527
Activase® Alteplase 100 mg Injection Vial 58 Million IU

Features
  • Activase is a tissue plasminogen activator (tPA) indicated for the treatment of Acute Ischemic Stroke (AIS), Acute Myocardial Infarction (AMI) to reduce mortality and incidence of heart failure or Acute Massive Pulmonary Embolism (PE) for lysis
  • Activase is proven to reduce disability in patients treated within 3 hours of symptom onset
  • Each 100 mg Activase vial (58 million IU) is packaged with diluent for reconstitution (100 mL Sterile Water for Injection, USP), and one transfer device
  • More …
Container Type
Single Use Vial Vial
Generic Drug Code
47140 47142
Strength
50 mg 100 mg
Volume
29 Million IU 58 Million IU
  Log In to Order
or

Professionals Also Viewed


Product Specifications


McKesson #904182
Manufacturer #50242008527
BrandActivase®
ManufacturerGenentech USA
Country of OriginUnknown
Alternate Manufacturer Number2430254
ApplicationThrombolytic Agent
Container TypeVial
Dosage FormInjection
Generic Drug Code47142
Generic Drug NameAlteplase
NDC Number50242-0085-27
Storage RequirementsUSP Controlled Room Temperature
Strength100 mg
TypeIntravenous
UNSPSC Code51412702
Volume58 Million IU
Features
  • Activase is a tissue plasminogen activator (tPA) indicated for the treatment of Acute Ischemic Stroke (AIS), Acute Myocardial Infarction (AMI) to reduce mortality and incidence of heart failure or Acute Massive Pulmonary Embolism (PE) for lysis
  • Activase is proven to reduce disability in patients treated within 3 hours of symptom onset
  • Each 100 mg Activase vial (58 million IU) is packaged with diluent for reconstitution (100 mL Sterile Water for Injection, USP), and one transfer device
More Information